News

FDA approves fixed-dose combination for patients with hypertension

26.01.20151911

Symplmed Pharmaceuticals announced that the FDA has approved the fixed-dose combination of perindopril arginine and amlodipine for the treatment of hypertension in patients whose BP is not adequately controlled on monotherapy.

Heart muscle regeneration induced by long-term use of ventricular assist devices

23.01.20151712

Prolonged use of a left ventricular assist device (LVAD) by patients with heart failure may induce regeneration of heart muscle by preventing oxidative damage to a cell-regulator mechanism, UT Southwestern Medical Center investigators have found.

New oral anticoagulants in the treatment of heparin- induced thrombocytopenia

22.01.20152905

There are little data on the efficacy of new oral anticoagulants (NOAC) in this setting.

University of Michigan hospital discharges patient with artificial heart

21.01.20151576

The University of Michigan Frankel Cardiovascular Center recently discharged a 24-year old patient with a total artificial heart, allowing him to return home without a human heart while he waits for a heart transplant.

Cerebrovascular disease often linked to Alzheimer’s disease

20.01.20152108

Cerebrovascular disease is often associated with Alzheimer’s disease, and especially with cognitive decline, according to researchers.

Battle of the scholars 2015: who will be the first among equals?

19.01.20152690

We invite you to take part in the competition on knowledge of practice guidelines that will be based on clinical cases.

ANNEXA-R: Antidote to novel oral anticoagulant met primary endpoint

19.01.20152007

Portola Pharmaceuticals announced topline results of the phase 3 ANNEXA-R study demonstrating that andexanet alfa, an antidote to the anticoagulant effects of Factor Xa inhibitors, met the primary endpoint with high statistical significance.